Healthcare News

Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer

EVX-01 induced an immune response in all patients in the trial with 89% of the vaccine neoantigens generating potent specific T-cell responses Three-year data from the EVX-01 phase 2 trial in patients...

Louvain-la-Neuve, Belgium, October 23, 7 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial...

Louvain-la-Neuve, Belgique, le 23 octobre 2026, 7h00 - IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélérateurs de particules et des solutions de faisceaux...

Pratteln, Switzerland, October 23, 2026 – Santhera Pharmaceuticals (SIX: SANN) today notes that its licensing partner Nxera Pharma Co., Ltd. (“Nxera”) has submitted a Marketing Authorization...

Pratteln, Schweiz, 23. Oktober 2026 – Santhera Pharmaceuticals (SIX: SANN) gibt heute bekannt, dass sein Lizenzpartner Nxera Pharma Co., Ltd. (“Nxera“) beim südkoreanischen Ministerium für...

Fangzhou was invited to showcase its “AI + Chronic Disease Services” solution at the 2026 Fortune China 500 Forum in Chengdu.

Buena Park, CA, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Orange Hospice has received BusinessRate’s Best of 2026 Award in the Hospice category for Buena Park, California, as it marks five years of service....

RIYADH, Arabie saoudite, 23 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a renforcé sa capacité de prise en charge des soins complexes en repensant le...

RIAD, Saudi-Arabien, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital and Research Centre (KFSH) hat seine Kapazitäten für die komplexe Versorgung durch eine Neugestaltung des...